Impella Supported OPCABG

Active, not recruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

May 11, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

March 31, 2026

Conditions
Ischemic Cardiomyopathy
Interventions
DEVICE

Impella 5.5 with SmartAssist Supported OPCABG

Subjects will undergo insertion of an axillary or ascending aortic Impella 5.5 with SmartAssist, followed by Impella-supported OPCABG using a sternotomy approach with shunting of the coronary arteries to achieve myocardial protection.

Trial Locations (1)

53226

The Medical College of Wisconsin, Milwaukee

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Abiomed Inc.

INDUSTRY

lead

Lucian Archambault Durham III

OTHER

NCT04339452 - Impella Supported OPCABG | Biotech Hunter | Biotech Hunter